Suchergebnisse - "Branger, Pierre"

PubPharm (44)

1

Corticospinal tract hyperintensity in patients with LGI1-antibody encephalitis and other central nervous system disorders with neuroglial antibodies

enthalten in: Journal of neuroimmunology | 2024

von Campetella, L. | Villagrán-García, M. | Farina, A. | +23

2

Impact of Immune Checkpoint Inhibitors on the Course of Multiple Sclerosis

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2024

von Androdias, G. | Noroy, L. | Psimaras, D. | +21

ErratumIn: Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200245. - PMID 38484219

3

COVID-19 outcomes in patients with multiple sclerosis : Understanding changes from 2020 to 2022

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2024

von Jeantin, L. | Januel, E. | Labauge, P. | +27

4

Cancer and multiple sclerosis : 2023 recommendations from the French Multiple Sclerosis Society

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2024

von Collongues, N. | Durand-Dubief, F. | Lebrun-Frenay, C. | +36

5

Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder

enthalten in: Neurology(R) neuroimmunology & neuroinflammation | 2024

von Carta, S. | Dinoto, A. | Capobianco, M. | +24

6

Assessment of Mendelian and risk-factor genes in Alzheimer disease : A prospective nationwide clinical utility study and recommendations for genetic screening

enthalten in: Genetics in medicine : official journal of the American College of Medical Genetics | 2024

von Nicolas, G. | Zaréa, A. | Lacour, M. | +98

7

Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome : The TERIS Randomized Clinical Trial

enthalten in: JAMA neurology | 2023

von Lebrun-Frénay, C. | Siva, A. | Sormani, M. | +74

8

Association Between Anti-CD20 Therapies and COVID-19 Severity Among Patients With Relapsing-Remitting and Progressive Multiple Sclerosis

enthalten in: JAMA network open | 2023

von Januel, E. | Hajage, D. | Labauge, P. | +25

9

Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort

enthalten in: Neurology and therapy | 2023

von Pelle, J. | Briant, A. | Branger, P. | +18

10

Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort

enthalten in: Neurology and Therapy | 2023

von Pelle, J. | Briant, A. | Branger, P. | +18

1
2
3
4
5
Nächster »
[5]